A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer

Clinical trial NCT07381829 · RECRUITING

Trial details

NCT number: NCT07381829
Sponsor: HC Biopharma Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Cancer

Start date: 2025-10-27
Primary completion: 2026-12-30
Enrollment: 328

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.